{"id":"W2205041904","doi":"10.1007/s10637-015-0316-5","title":"Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers","year":2015,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Vandetanib; Capecitabine; Gemcitabine; Medicine; Internal medicine; Pancreatic cancer; Gastroenterology; Tyrosine-kinase inhibitor; Oncology; Neutropenia; Cancer; Chemotherapy; Sorafenib; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001362791,0.001567462,0.002674018,0.0004558612,0.0004863303,0.001492126,0.0008585855,0.0008182342,0.003194081],"category_scores_gemma":[0.000952975,0.0007443973,0.001780642,0.0006299768,0.0008653649,0.001085422,0.0005143821,0.003723325,0.0007304449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001293386,"about_ca_system_score_gemma":0.001783859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001967358,"about_ca_topic_score_gemma":0.006888956,"domain_scores_codex":[0.9995888,0.0001735136,0.00001924698,0.00008659501,0.000031498,0.000100393],"domain_scores_gemma":[0.999421,0.00009313202,0.00008246169,0.00005406175,0.00003213474,0.0003172738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8087493,0.0330389,0.01160853,0.0007346591,0.003178801,0.0003304851,0.0003357566,0.005847318,0.02380036,0.0004432848,0.008325858,0.1036068],"study_design_scores_gemma":[0.7512102,0.20935,0.02536912,0.00005314891,0.001470444,0.0004408988,0.0001784084,0.002820808,0.002524744,0.0003831655,0.006142983,0.00005621899],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916535,0.002585724,0.0003652729,0.0007466349,0.0002343227,0.0009791231,0.001227893,0.00009188505,0.002115658],"genre_scores_gemma":[0.9857599,0.00317195,0.001561998,0.000773811,0.0002196374,0.001240053,0.004104035,0.00006151302,0.003107043],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003194081,"threshold_uncertainty_score":0.01068532,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02157323949200639,"score_gpt":0.3128161131465707,"score_spread":0.2912428736545642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}